HealthEquity (NASDAQ:HQY) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Young Americans Lead in HSA Adoption But Carry Heaviest Economic Burden, HealthEquity Research Finds
HealthEquity (NASDAQ:HQY) was given a new $118.00 price target on by analysts at Barclays PLC.
HealthEquity (NASDAQ:HQY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
HealthEquity (NASDAQ:HQY) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $125.00 price target on the stock.